Canada has become the first market outside the United States and Europe to approve Jetrea for the treatment of symptomatic vitreomacular adhesion, according to a news release.Jetrea (ocriplasmin, ThromboGenics) was approved by Health Canada via priorit…
Omega-3 rich oils improve membrane fluidity in retina cells and can help fight age-related eye diseases
Scientists working at the Research Center on Aging at the Health and Social Services Centre – University Institute of Geriatrics of Sherbrooke (CSSS-IUGS) have been studying strategies for protecting retinal pigment epithelium (RPE) cells…
Good news for people who lose their foveal vision due to macular diseases
When something gets in the way of our ability to see, we quickly pick up a new way to look, in much the same way that we would learn to ride a bike, according to a new study published in the Cell Press journal Current Biology. Our eyes are constantly o…
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Status: Not yet recruiting,
Condition Summary: Thyroid Eye Disease; Ocular Hypertension; Glaucoma
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Status: Not yet recruiting,
Condition Summary: Thyroid Eye Disease; Ocular Hypertension; Glaucoma
Glaucoma Diagnostic Ability of Ganglion Cell–Inner Plexiform Layer Thickness Differs According to the Location of Visual Field Loss – Corrected Proof
Objective: To determine whether the ganglion cell–inner plexiform layer (GCIPL) or circumpapillary retinal nerve fiber layer (cpRNFL) is better at distinguishing eyes with early glaucoma from normal eyes on the basis of the the initial location of th…